N-[(2-Pyridyl)methyliden]-6-coumarin (L) is synthesized by the condensation of 6-aminocoumarin and pyridine-2-carboxaldehyde. Group-6 tetracarbonyl complexes, [M(CO)(4)(L)] (M=Cr, Mo, and W) are synthesized and characterized by mass spectrometry and NMR, FT-IR and UV-visible spectroscopy. X-ray crystal structure of [Cr(CO)(4)(L)] shows N(pyridine), N(imine) chelation to chromium(0). A supramole...

In the centrosymmetric polymeric title compound, {[CoEr(2)(C(14)H(8)N(2)O(5))(4)(H(2)O)(4)]·4H(2)O}(n), the Er(III) cation has a coordination number of eight and is surrounded by seven carboxyl-ate O atoms from four 5-(pyridine-4-carboxamido)-isophthalate (L) ligands and one water mol-ecule, forming a distorted square-anti-prismatic arrangement. The Co(II) cation is located on an inversion cent...

A new iridium catalyst containing an imine-diphosphine ligand has been developed, which showed high efficiency for the hydrogenation of CO2 to formate (yield up to 99%, TON up to 450 000). A possible catalytic mechanism is proposed, in which the imine group of the catalyst plays a key role in the cleavage of H2 and the activation of CO2.

The complex molecule in the title compound, [NiBr2(C36H40N2)], has mirror symmetry. The Ni(II) atom and two Br atoms are located on the mirror plane. The Ni(II) atom is four-coordinated by the two Br atoms and two N atoms from an N,N'-bis(2,6-diethyl-4-phenyl-phen-yl)butane-2,3-di-imine ligand in a distorted tetra-hedral geometry. The dihedral angle formed between the two adjacent benzene rings...

An efficient synthesis of 5-bromo-2-methoxy-6-methylaminopyridine-3-carboxylic acid (1), a carboxylic acid moiety of a potent dopamine D2 and D3 and serotonin-3 (5-HT3) receptors antagonist, (R)-5-bromo-N-(1-ethyl-4-methylhexahydro-1 ,4-diazepin-6-yl)-2-methoxy-6-methylaminopyridine-3-carboxamide, is described. Reaction of methyl 2,6-difluoropyridine-3-carboxylate (12) with methylamine in EtOH ...

Neutral chloromethylpalladium(II) complexes, [Pd(Cl)(CH3)(L)] (1a-5a) with ligands κ(2)-N^S-2-((3,5-di-tert-butyl-1H-pyrazol-1-yl)methyl)-6-(phenylthiomethyl)pyridine (L1), κ(2)-N^S-2-((3,5-dimethyl-1H-pyrazol-1-yl)methyl)-6-(phenylthiomethyl)pyridine (L2), κ(2)-N^Se-2-((3,5-di-tert-butyl-1H-pyrazol-1-yl)methyl)-6-(phenylselanylmethyl)pyridine (L3), κ(2)-N^Se-2-((3,5-dimethyl-1H-pyrazol-1-yl)me...

Treatment of the Fe(I) mesityl complex [Fe(Mes)(BPEP-Ph)] (BPEP-Ph = 2,6-bis[1-phenyl-2-(2,4,6-tri-tert-butylphenyl)-2-phosphaethenyl]pyridine) with π-acid ligands (L = CO, RNC) leads to one-electron reduction via Mes group migration from Fe to P, followed by homolytic elimination of the 2,4,6-tBu3C6H2 group, to afford Fe(0) complexes of the formula [Fe(L)2(BPEP-Ph*)] (BPEP-Ph* = 2-[1-phenyl-2-...

The asymmetric unit of the title compound, [Co(NO3)2L] n , L = N-(pyridine-2-ylmeth-yl)pyridine-3-amine (C11H11N3), contains one CoII centre, two nitrate anions and one L ligand in which the Cpy-C-N-Cpy moiety adopts a trans conformation with a torsion angle of -173.1 (3) Å. The coordination geometry of the CoII atom is a distorted penta-gonal bipyramid. One amine N atom from the L ligand and f...